HIV In Children
   
 
User Name Password Remember Me
 
 
   
Video Podcast
Audio Cast
Mobile(WAP)
  Pedi Poll  
Should all married couples undergo testing to check if they are thalassemia minor_?
Yes
No
  Translate This Page  
 
COMPARATIVE STUDY OF TWO EPIDEMICS OF DENGUE FEVER IN SAME SETTING AT AN INTERVAL OF 2 YEARS
KARNATAKA PEDICON 2006

Narayanappa*, Rizwan Ahmed**
*Professor & H.O.D. **P.G, Department of pediatrics, J.S.S. Medical College, Mysore.
Email: ahmed_rizwan59@rediffmail.com
Introduction
Dengue is a very important arboviral disease of human beings. It is a vector borne disease transmitted mainly by Aedes Aegypti Mosquito. Four Serotypes of Dengue Viruses have been recognized - DEN-1, DEN-2, DEN-3, DEN-4.

First infection with any of the Serotypes of Dengue virus causes a self limiting benign illness.

Recovery from first episode is accompanied by immune responses. These responses are characterized by development of homotypic neutralizing antibodies and heterotypic non neutralizing antibodies.

Homotypic antibodies confer life long immunity against infecting strain

During infection by other strains Heterotype non neutralizing antibodies act as virus specific receptors promoting entry of viruses into Mononuclear phagocytes and thus convert mild infection into severe one. This mechanism where antibodies help in augmenting the infection is known as Antibody dependant enhancement.

AIMS AND OBJECTIVES
Aim was to study the clinical profile and outcome of epidemics of Dengue in and around Mysore and comparison of the outcome of 2 epidemics, 2 years apart in same setting.

Subjects and Methods :
This was a prospective study done on cases of Dengue fever and Dengue Hemorrhagic Fever admitted in Dept. of Pediatrics, JSS Hospital Mysore from June 1, 2003 to September 03, 2003 and from June 1, 2005 to Nov. 15, 2005 .

Children admitted with symptoms of Fever, Myalgia, Headache. Retro orbital pain, Bleeding, Altered sensorium, Shock or low platelet count were provisionally diagnosed as Dengue and investigated for IgM / IgG by Elisa or Dot method.

Those children testing +ve Either for IgM/ IgG were diagnosed as Dengue. They were included in the study and followed up for clinical profile from admission till discharge.

  • Children were grouped according to WHO Definition.
  • A total no. of 70 cases were diagnosed as Dengue by Serology in both episodes
  • Lab investigations carried out included Hb , WBC Count, Differential WBC count, Platelet count ,hematocrit.
Platelet Transfusion was given to children having

  1. Platelet count < 50,000 with bleeding.
  2. Platelet Countl < 20,000 with / without bleeding.
  •   All the children received iv fluids depending upon weight and Hydration status of the child.
  •   Virus isolation and Serotyping could not be done because of lack of lab facility.

  • Results :

    70 Seropositive cases were Diagnosed in both epidemics.

    • Outcomes of both epidemics were compared with respect to clinical features ,complications ,and mortality

    AGE DISTRIBUITION

      Age

      2003 epidemic(% age )

      2005 epidemic(%age)

      <1 year

      4

      1

      1 to 3 years

      31

      16

      4 to 6 years

      27

      29

      7 to 9 years

      23

      27

      10 to 14 years

      15

      27


    Clinical features

    Percentage of children affected

      (a) Symptoms

      2005 epidemic(%)

      2003 epidemic(%)

      Fever

    97

    100

      Vomiting

    30

    42.3

      Pain abdomen

    20

    42.3

      Cough

    14

    27

      Bleeding Manifestation

    10

    23

      Headache

    8.5

    5.8

      Altered sensorium

    4.2

    5.7

      Body pain

    4.2

    9.6

      Convulsions

    2.8

    3.8

      (b) Signs

    -
    -

      Hepatomegaly

    90

    57.7

      Splenomegaly

    70

    21.2

      Lymphaedenopathy

    50

    5.6

      Ascitis

    31.42

    28.5

      Facial puffiness and Pedal edema

    20

    5.7

      Shock

    17

    10

      Conjuctival suffusion

    14.2

    15

      Rashes

    14.2

    36.5

      Bleeding Manifestation

    8.5

    11.5

      Hess test positive

    1.3

    4



    • Fever was the Commonest sympton followed by vomiting .

    • Hepatomegaly was the commonest sign followed by Splenomegaly and lymphaedenopathy.

    • Bleeding manifestations were seen in 10 % cases in the present epidemic whereas it was seen in 23% cases in previous epidemic

    • Petechiae was the commonest bleeding manifestation seen in 3 cases in 2005 epidemic. Whereas hematemesis was the commonest bleeding manifestation in 2003 epidemic.

    Thrombocytopenia (platelet count<1 lakh)

      Present epidemic (2005): 43%

      Previous epidemic (2003):


    Types of dengue

    2005 epidemic

    2003 epidemic

    Total No. of cases

    70

    70

                 DF

    74.2 %(52)

    65.7 %(45)

                 DHF

    5.7 %(4)

    20 %(14)

                 DSS

    17 %(12)

    10 %(8)

                 DFB

    2.83 %(2)

    4.3 %(3)


    BFB stands for dengue fever with unusual bleed which mean patients of dengue having bleeding in absence of thrombocytopenia.

    DF -dengue fever . DHF-dengue hemorrhagic fever
    DSS-dengue shock syndrome

    COMPLICATIONS

    2005 epidemic (no of cases)

    2003 epidemic (no of cases)

              Meningoencephalitis

    6

    nil

              Adult Respiratory Distress           Syndrome

    7

    nil

              Myocarditis

    2

    nil

              Pericarditis

    1

    nil

              Acute Renal failure

    2

    nil

              Hepatitis

    1

    nil

              Mortality

    4(5.7%)

    nil


    MORTALITY(2005 epidemic)

              Cause of death

    Total No.

              Adult Respiratory Distress Syndrome

    3

              DSS with Myocarditis

    1

              Total

    4 (5.7 %)

              Complications and mortality were nil in previous study

    -

    Discussion :
    In the present epidemic (2005) of dengue, complications like shock, ARDS, meningoencephalitis, ARF were seen. Mortality was also significant. Mortality and complications were nil in previous epidemics. Severe form of dengue in recent epidemic must be because of secondary dengue infection and antibody dependant enhancement. Because of lack of lab facility ,virus isolation and serotyping could not be done .

    ARDS was the commonest cause of death, .hence child has to be watched carefully for respiratory distress

    Conclusions:
    1. Be prepared to face a severe form of secondary dengue infection following a simple dengue epidemic.

    2. Advise Anti-mosquito measures to an individual who recovers simple Dengue infection to prevent secondary dengue fever which threatens life.


    Last Updated on 15-11-2006

    How to cite this url
    Karnataka Pedicon 2006 - Conference Abstracts.Pediatric Oncall [serial online] 2006 [cited 15 November 2006(Supplement 11)];3. Available from:
    http://www.pediatriconcall.com/fordoctor/Conference_abstracts/
    KARNATAKA_PEDICON/comparative_study_dengue_fever.asp
     
      Search  
    Hospitals
    Pediatrician
    Special Schools
    Medical Colleges
    Pediatric Conferences
    Jobs & Vacancies
    Journals
      Ped Tools  
    Pediatric Calculator
    Drug Index
    Medical Equipment
    Vaccine Reminder
    Adverse Drug Reactions
    Biochemical Profile
      Calculators  
    + Serum Osmolality
    + A-a Gradient
    + Bicarbonate & Base
        Excess
    + Basal Metabolic Rate
    + Body Mass Index
    + Body Surface Area
    + Height
    + Weight
    + Head Circum.
    + Predict Height
     
     
    Parent Corner l Kids Corner l Terms & Condition l Privacy Statement | Advertising l Feedback | Awards
    Newsletter | About Us l Link to Us l Site Map l Shopping Mall l Media Room  
    Partner Sites
     HIV in Children  Infection in Children  Pedcall  Medical ADRIS  Vaccine Reminder  Pediatric Oncall Journal
    Health Solutions from our sponsors
     DHA  Surfactant  Nutrition    

    Copyright© 2000-2008 All rights reserved with Pediatric Oncall

    Disclaimer:The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitue an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.

     
    Sitemap For Doctor | Sitemap For Parent | Sitemap For Kids Site designed and maintained by Levioza